The START Center for Cancer Research announced the launch of the START Hope Hub, a digital platform providing access to over 720 active oncology clinical trials. Designed for patients, physicians, and ...

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine ...

Presented at ASCO 2025, new post-hoc analyses from the Phase III ARANOTE trial showed that darolutamide (Nubeqa) plus ADT ...

The results from ATOMIC trial, presented at ASCO 2025, show that adding atezolizumab (Tecentriq) to FOLFOX chemotherapy halved the risk of recurrence or death in stage III dMMR colon cancer, boosting ...

ONCOLife presents an exclusive interview with Nick Slack, Chairman and CEO of The START Center for Cancer Research. In this session, we explore how the integration of the Carolina Urologic Research ...

The first AI-powered companion diagnostic for non-small cell lung cancer (NSCLC) has received FDA Breakthrough Device Designation. Developed by Roche, Ventana TROP2 RxDx Device combines ...

We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...

The Phase 3 ASCENT-04 clinical trial has demonstrated that combining the antibody-drug conjugate Trodelvy® with the immunotherapy Keytruda® significantly improves progression-free survival in patients ...

Oncolytic viruses are emerging as a promising development in cancer treatment, not only destroying cancer cells but also modulating the tumor microenvironment to enhance immune responses. We had an ...

Noval ADC candidate ADRX-0706 received FDA Fast Track designation for advanced cervical cancer. Targeting Nectin-4 with a novel IgG1 antibody and AP052 payload, ADRX-0706 showed promising safety and ...